Relationship between glucocorticoid receptor signal pathway and androgen-independent prostate cancer

Urologia Internationalis

Volumn 81, Issue 2, 2008, Pages 228-233

  Yan, Tian Zhong ^a   Jin, Feng Shuo ^b   Xie, Li Ping ^a   Li, Long Cheng ^c  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Glucocorticoid receptor; Heat shock protein; Interleukin; Prostate cancer, androgen independent

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; CYTOKINE; GLUCOCORTICOID RECEPTOR; HEAT SHOCK PROTEIN 90; INTERLEUKIN 6; MIFEPRISTONE;

ANDROGEN INDEPENDENT PROSTATE CANCER; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DISEASE COURSE; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

CELL LINE, TUMOR; HORMONE ANTAGONISTS; HSP90 HEAT-SHOCK PROTEINS; HUMANS; INTERLEUKIN-6; MALE; MIFEPRISTONE; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; RECEPTORS, GLUCOCORTICOID; SIGNAL TRANSDUCTION;

EID: 50849087319     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000144067     Document Type: Article

References (20)

1. Suzuki H, Sato N, Watabe Y, Masai M, Seino S, Shimazaki J: Androgen receptor gene mutations in human prostate cancer. J Steroid Biochem Mol Biol 1993;46:759-765.
2. Ruizeveld de Winter JA, Janssen PJ, Sleddens HM, Verleun-Mooijman MC, Trapman J, Brinkmann AO, Santerse AB, Schroder FH, van der Kwast TH: Androgen receptor status in localized and locally progressive hormone refractory human prostate cancer. Am J Pathol 1994;144:735-746.
3. Zhang J, Thomas TZ, Kasper S, Matusik RJ: A small composite probasin promoter confers high levels of prostate-specific gene expression through regulation by androgens and glucocorticoids in vitro and in vivo. Endocrinology 2000;141:4698-4710.
4. Culig Z, Bartsch G, Hobisch A: Interleukin-6 regulates androgen receptor activity and prostate cancer cell growth. Molecular 2002;197:231-238.
5. Smith PC, Hobisch A, Lin DL, Culig Z, Keller ET: Interleukin-6 and prostate cancer progression. Cytokine Growth Factor Rev 2001;12:33-40.
6. Berns EM, de Boer W, Mulder E: Androgen-dependent growth regulation of and release of specific protein(s) by the androgen receptor containing human prostate tumor cell line LNCaP. Prostate 1986;9:247-259.
7. Brolin J, Skoog L, Ekman P: Immunohistochemistry and biochemistry in detection of androgen, progesterone, and estrogen receptors in benign and malignant human prostatic tissue. Prostate 1992;20:281-295.
8. Alen P, Claessens F, Schoenmakers E, Swinnen JV, Verhoeven G, Rombauts W, Peeters B: Interaction of the putative androgen receptor-specific coactivator ARA70/ELE1alpha with multiple steroid receptors and identification of an internally deleted ELE1beta isoform. Mol Endocrinol 1999;13:117-128.
9. Mohler JL, Chen Y, Hamil K, Hall SH, Cidlowski JA, Wilson EM, French FS, Sar M: Androgen and glucocorticoid receptors in the stroma and epithelium of prostatic hyperplasia and carcinoma. Clin Cancer Res 1996;2:889-895.
10. Nishimura K, Nonomura N, Satoh E, Harada Y, Nakayama M, Tokizane T, Fukui T, Ono Y, Inoue H, Shin M, Tsujimoto Y, Takayama H, Aozasa K, Okuyama A: Potential mechanism for the effects of dexamethasone on growth of androgen-independent prostate cancer. J Natl Cancer Inst 2001;93:1739-1746.
11. Davies P, Rushmere NK: Association of glucocorticoid receptors with prostate nuclear sites for androgen receptors and with androgen response elements. J Mol Endocrinol 1990;5:117-127.
12. Cleutjens CB, Steketee K, van Eekelen CC, van der Korput JA, Brinkmann AO, Trapman J: Both androgen receptor and glucocorticoid receptor are able to induce prostate-specific antigen expression, but differ in their growth-stimulating properties of LNCaP cells. Endocrinology 1997;138:5293-5300.
13. Jenkins BD, Pullen CB, Darimont BD: Novel glucocorticoid receptor coactivator effector mechanisms. Trends Endocrinol Metab 2001;12:122-126.
14. Bone RC: Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: what we do and do not know about cytokine regulation. Crit Care Med 1996;24:163-172.
15. Drachenberg DE, Elgamal AA, Rowbotham R, Peterson M, Murphy GP: Circulating levels of interleukin-6 in patients with hormone refractory prostate cancer. Prostate 1999;41:127-133.
16. Dondi D, Maggi R, Scaccianoce E, Martini L, Motta M, Poletti A: Expression and role of functional glucocorticoid receptors in the human androgen-independent prostate cancer cell line, DU145. J Mol Endocrinol 2001;26:185-191.
17. Albrecht M, Janssen M, Konrad L, Renneberg H, Aumuller G: Effects of dexamethasone on proliferation of and fibronectin synthesis by human primary prostatic stromal cells in vitro. Andrologia 2002;34:11-21.
18. Henning U, Krieger K, Loeffler S, Rivas F, Orozco G, de Castro MG, Rietschel M, Noethen MM, Klimke A: Increased levels of glucocorticoid receptors and enhanced glucocorticoid receptor auto-regulation after hydrocortisone challenge in B-lymphoblastoids from patients with affective disorders. Psychoneuroendocrinology 2005;30:325-332.
19. Kumar R, Thompson EB: Gene regulation by the glucocorticoid receptor: structure: function relationship. J Steroid Biochem Mol Biol 2005;94:383-394.
20. Vanaja DK, Mitchell SH, Toft DO, Young CY: Effect of geldanamycin on androgen receptor function and stability. Cell Stress Chaperones 2002;7:55-64.